← Back to Patent Explorer
US5178635A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for determining amount of medication in an implantable device

Assignee: Allergan Inc
•
Filing: 1992-05-04
•
Granted: 1993-01-12
•
Expires: 2012-05-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A system for providing controlled release of an active agent in an eye includes a device with a shape thereof for enabling placement of the device under a conjunctiva of an eye and additionally preventing migration of the device in the eye after placement of the device under the conjunctiva. The device may be formed of a material permeable to the passage of an agent disposed in said device. In addition, a tracer may be incorporated in the device to enable visual indication of the amount of active agent in said device when said device is disposed under the conjunctiva. To selectively treat specific areas of the eye, an impermeable layer may be provided for preventing diffusion of the active agent from a selected area of the device.

Inventors

  • 👤 Arlene E. Gwon
  • 👤 David Meadows

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 19:02
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0048; A61K9/0051; A61F; A61F9/00; A61F9/0008; A61F9/0017; A61M; A61M31/00; A61M31/002

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 52 words
A method for determining an amount of medication in a device, said method comprising the steps of: disposing a device having means for visibly indicating the amount of medication therein beneath a tissue layer of a subject; and visually observing the indicated amount of medication in the device through the tissue layer.
Claim 2
Independent Claim 52 words
A method for determining an amount of medication in a device, said method comprising the steps of: disposing a device having means for visibly indicating the amount of medication therein beneath a tissue layer of a subject; and visually observing the indicated amount of medication in the device through the tissue layer.
Claim 3
Dependent Claim 28 words
The method according to claim 1 wherein the step of disposing the device beneath a tissue layer comprises placing of the device under a conjunctiva of an eye.
Claim 4
Dependent Claim 35 words
The method according to claim 2 wherein the step of visually observing an indicated amount of medication comprises illuminating the device through the tissue layer in order to visually observe the indicated amount of medication.
Claim 5
Dependent Claim 37 words
The method according to claim 3 wherein the step of visually observing an indicated amount of medication comprises illuminating the device through the tissue layer with ultraviolet light in order to observe the indicated amount of medication.

References Cited (Backward Citations)

US3995635A Cited
US4052505A Cited
US5098443A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-01-12 1996-07-13 1997-01-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-01-12 2000-07-13 2001-01-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-01-12 2004-07-13 2005-01-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag